Entry Point Capital, LLC Ardelyx, Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 16,399 shares of ARDX stock, worth $93,310. This represents 0.07% of its overall portfolio holdings.
Number of Shares
16,399
Previous 1,657
889.68%
Holding current value
$93,310
Previous $12.3 Million
99.09%
% of portfolio
0.07%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
219Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$123 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$99.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$77.4 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$69.1 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$50.9 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $880M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...